How has been the historical performance of Fredun Pharma?

Answer:The historical performance of Fredun Pharma shows a consolidated net profit of 19.74 crore for the year ending March 2025, with a profit before tax of 27.49 crore and a profit after tax margin of 4.37%. The total operating income for the same period was 456.27 crore, while total expenditure, excluding depreciation, was 401.36 crore, resulting in an operating profit (PBDIT) of 54.91 crore. The company reported an operating profit margin of 12.16% and a gross profit margin of 7.2%. Earnings per share stood at 41.82, with diluted earnings per share at 44.83.

Breakdown:
In the fiscal year ending March 2025, Fredun Pharma achieved total operating income of 456.27 crore, primarily driven by net sales, while incurring total expenditures of 401.36 crore, which included raw material costs of 323.98 crore and various operational expenses. This led to an operating profit of 54.91 crore, reflecting a solid operating profit margin of 12.16%. The company’s profit before tax was recorded at 27.49 crore, with a net profit of 19.74 crore after accounting for taxes. The earnings per share were reported at 41.82, indicating a positive return for shareholders, alongside a healthy cash flow management reflected in the closing cash and cash equivalents of 1.00 crore as of March 2024.